Two-component carnitine monooxygenase from Escherichia coli: functional characterization, inhibition and mutagenesis of the molecular interface.


Journal

Bioscience reports
ISSN: 1573-4935
Titre abrégé: Biosci Rep
Pays: England
ID NLM: 8102797

Informations de publication

Date de publication:
30 09 2022
Historique:
received: 18 05 2022
revised: 16 08 2022
accepted: 06 09 2022
pubmed: 7 9 2022
medline: 24 9 2022
entrez: 6 9 2022
Statut: ppublish

Résumé

Gut microbial production of trimethylamine (TMA) from l-carnitine is directly linked to cardiovascular disease. TMA formation is facilitated by carnitine monooxygenase, which was proposed as a target for the development of new cardioprotective compounds. Therefore, the molecular understanding of the two-component Rieske-type enzyme from Escherichia coli was intended. The redox cofactors of the reductase YeaX (FMN, plant-type [2Fe-2S] cluster) and of the oxygenase YeaW (Rieske-type [2Fe-2S] and mononuclear [Fe] center) were identified. Compounds meldonium and the garlic-derived molecule allicin were recently shown to suppress microbiota-dependent TMA formation. Based on two independent carnitine monooxygenase activity assays, enzyme inhibition by meldonium or allicin was demonstrated. Subsequently, the molecular interplay of the reductase YeaX and the oxygenase YeaW was addressed. Chimeric carnitine monooxygenase activity was efficiently reconstituted by combining YeaX (or YeaW) with the orthologous oxygenase CntA (or reductase CntB) from Acinetobacter baumannii. Partial conservation of the reductase/oxygenase docking interface was concluded. A structure guided mutagenesis approach was used to further investigate the interaction and electron transfer between YeaX and YeaW. Based on AlphaFold structure predictions, a total of 28 site-directed variants of YeaX and YeaW were kinetically analyzed. Functional relevance of YeaX residues Arg271, Lys313 and Asp320 was concluded. Concerning YeaW, a docking surface centered around residues Arg83, Lys104 and Lys117 was hypothesized. The presented results might contribute to the development of TMA-lowering strategies that could reduce the risk for cardiovascular disease.

Identifiants

pubmed: 36066069
pii: 231753
doi: 10.1042/BSR20221102
pmc: PMC9508527
pii:
doi:

Substances chimiques

Disulfides 0
Methylamines 0
Methylhydrazines 0
Sulfinic Acids 0
allicin 3C39BY17Y6
3-(2,2,2-trimethylhydrazine)propionate 73H7UDN6EC
Flavin Mononucleotide 7N464URE7E
Mixed Function Oxygenases EC 1.-
Oxidoreductases EC 1.-
Oxygenases EC 1.13.-
trimethylamine LHH7G8O305
Carnitine S7UI8SM58A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022 The Author(s).

Références

J Biol Chem. 2009 Jun 5;284(23):15530-40
pubmed: 19336405
J Biol Chem. 2020 Jul 24;295(30):10493-10505
pubmed: 32503843
Science. 2012 Jun 8;336(6086):1262-7
pubmed: 22674330
J Bacteriol. 1993 Sep;175(18):5877-81
pubmed: 8376335
Cell. 2015 Dec 17;163(7):1585-95
pubmed: 26687352
J Biol Chem. 1963 Dec;238:3899-913
pubmed: 14086723
J Biochem. 1983 Apr;93(4):1027-36
pubmed: 6305926
Planta Med. 1991 Jun;57(3):263-70
pubmed: 17226157
Annu Rev Microbiol. 1992;46:277-305
pubmed: 1444257
Nutrients. 2018 Jun 24;10(7):
pubmed: 29937536
J Biol Chem. 2020 Sep 11;295(37):13065-13078
pubmed: 32694223
Molecules. 2017 May 10;22(5):
pubmed: 28489057
J Basic Microbiol. 2018 Jan;58(1):52-59
pubmed: 29110324
Nat Commun. 2015 Apr 07;6:6498
pubmed: 25849138
Methods. 2018 Oct 1;149:42-48
pubmed: 29684641
Environ Sci Technol. 2017 Jan 3;51(1):175-181
pubmed: 27792326
Bioorg Med Chem Lett. 2010 Sep 15;20(18):5541-3
pubmed: 20692829
Nature. 2006 Dec 21;444(7122):1027-31
pubmed: 17183312
Nature. 2006 Dec 21;444(7122):1022-3
pubmed: 17183309
NPJ Biofilms Microbiomes. 2021 Apr 16;7(1):36
pubmed: 33863898
ACS Catal. 2013 Oct 4;3(10):
pubmed: 24244885
Ann N Y Acad Sci. 2004 Nov;1033:30-41
pubmed: 15591001
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4268-73
pubmed: 24591617
Molecules. 2021 Mar 10;26(6):
pubmed: 33801955
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
J Biol Chem. 1987 Feb 5;262(4):1510-8
pubmed: 3805038
Anal Biochem. 1973 May;53(1):332-6
pubmed: 4145740
Biochemistry. 2006 Aug 1;45(30):9032-41
pubmed: 16866348
J Am Coll Cardiol. 2014 Nov 4;64(18):1908-14
pubmed: 25444145
Annu Rev Microbiol. 2015;69:305-21
pubmed: 26274026
Life Sci. 2014 Nov 11;117(2):84-92
pubmed: 25301199
J Biol Chem. 2021 Jan-Jun;296:100038
pubmed: 33158989
Circ Res. 2017 Mar 31;120(7):1183-1196
pubmed: 28360349
J Am Coll Cardiol. 2016 Jun 7;67(22):2620-8
pubmed: 27256833
J Bacteriol. 1999 May;181(9):2719-25
pubmed: 10217759
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
J Am Soc Nephrol. 2016 Jan;27(1):305-13
pubmed: 26229137
Electrophoresis. 2015 Sep;36(18):2207-2214
pubmed: 26081221
Nutr Res Pract. 2022 May;16(Suppl 1):S126-S133
pubmed: 35651834
Nat Commun. 2020 May 29;11(1):2676
pubmed: 32472090
Chembiochem. 2020 Jun 15;21(12):1733-1741
pubmed: 31958206
Front Mol Biosci. 2021 Oct 01;8:733507
pubmed: 34660695
Nature. 2011 Apr 7;472(7341):57-63
pubmed: 21475195
Biomed Res Int. 2014;2014:694967
pubmed: 25126572
J Chromatogr. 1989 Jun 23;472(2):347-56
pubmed: 2777944
Int J Mol Sci. 2019 Jul 11;20(14):
pubmed: 31373299
Biosci Biotechnol Biochem. 2001 Feb;65(2):254-63
pubmed: 11302156
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4592-8
pubmed: 20937873
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Nat Med. 2013 May;19(5):576-85
pubmed: 23563705
Science. 2006 Jun 2;312(5778):1355-9
pubmed: 16741115
Science. 1992 Dec 4;258(5088):1604-10
pubmed: 1280857

Auteurs

Fabian Piskol (F)

Institute of Microbiology, Technical University Braunschweig, Braunschweig, Germany.

Kerstin Neubauer (K)

Institute of Microbiology, Technical University Braunschweig, Braunschweig, Germany.

Maurice Eggers (M)

Institute of Microbiology, Technical University Braunschweig, Braunschweig, Germany.

Lisa Margarete Bode (LM)

Institute of Microbiology, Technical University Braunschweig, Braunschweig, Germany.

Jan Jasper (J)

Institute of Microbiology, Technical University Braunschweig, Braunschweig, Germany.

Alan Slusarenko (A)

Institut für Biologie III, RWTH Aachen University, Aachen, Germany.

Edward Reijerse (E)

Max-Planck-Institute for Chemical Energy Conversion, Mülheim an der Ruhr, Germany.

Wolfgang Lubitz (W)

Max-Planck-Institute for Chemical Energy Conversion, Mülheim an der Ruhr, Germany.

Dieter Jahn (D)

Braunschweig Centre of Integrated Systems Biology, Braunschweig, Germany.

Jürgen Moser (J)

Institute of Microbiology, Technical University Braunschweig, Braunschweig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH